Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 43

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 43
---
 Analysis” prepared by the Company’s management as required by Item 402(b) of Regulation S-K. Based on the review and discussions, the Compensation Committee recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement and incorporated by reference into the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Sharmila Dissanaike, M.D., FACS, FCCM, Chair

Craig Johnson

Susan Rodriguez

32

Executive Compensation Tables The following tables present information concerning the compensation paid to our NEOs. 2024 Summary Compensation Table

| Name and Principal Position    |     | Year |     | Salary |         |     | Stock      
 Awards (1) |         |     | Option     
 Awards (1) |           |     | Non-Equity       
 Incentive        
 Plan             
 Compensation (2) |         |     | All Other        
 Compensation (3) |         |     | Total |            |
|:-------------------------------|:----|-----:|:----|:-------|--------:|:----|:-----------|--------:|:----|:-----------|----------:|:----|:-----------------|--------:|:----|:-----------------|--------:|:----|:------|-----------:|
|                                |     | 2024 |     | $      | 669,500 |     | $          | 461,368 |     | $          | 1,687,180 |     | $                | 577,444 |     | $                |       — |     | $     |  3,395,492 |
| Craig Collard (4), (5)         
 Chief Executive Officer        |     | 2023 |     | $      | 492,986 |     | $          | 547,273 |     | $          | 9,257,049 |     | $                | 326,957 |     | $                | 151,553 |     | $     | 10,775,818 |
|                                |     | 2022 |     | $      |       — |     | $          |       — |     | $          |         — |     | $                |       — |     | $                |       — |     | $     |          — |
|                                |     | 2024 |     | $      | 515,000 |     | $          | 129